Eldad Zacksenhaus

5.1k citations
105 papers · 3.3k indexed · h-index 30
Topics
Cancer-related Molecular Pathways (32 papers)Ubiquitin and proteasome pathways (13 papers)Ocular Oncology and Treatments (11 papers)
Partner nations
CanadaChinaUnited States

In The Last Decade

Eldad Zacksenhaus

103 papers receiving 3.3k citations

Peers

Eldad Zacksenhaus
Comparison fields: 5 of 113
  • Molecular Biology 2.2k
  • Oncology 1.5k
  • Cancer Research 718
  • Pulmonary and Respiratory Medicine 310
  • Genetics 300
Replace H Matsushime with:
H Matsushime United States
Bernd Hinzmann Germany
Masayuki Komada Japan
S Krajewski United States
M. Raza Zaidi United States
John Easton United States
Arnaud Besson France
Sandy M. Price United States
Shuli Xia United States
Eldad Zacksenhaus relative to H Matsushime United States H Matsushime's profile →
Citations per field
00.5×
H Matsushime · 1×
Citations per year

Countries citing papers authored by Eldad Zacksenhaus

Since Specialization
Citations

This map shows the geographic impact of Eldad Zacksenhaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eldad Zacksenhaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eldad Zacksenhaus more than expected).

Fields of papers citing papers by Eldad Zacksenhaus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eldad Zacksenhaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eldad Zacksenhaus. The network helps show where Eldad Zacksenhaus may publish in the future.

Co-authorship network of co-authors of Eldad Zacksenhaus

This figure shows the co-authorship network connecting the top 25 collaborators of Eldad Zacksenhaus. A scholar is included among the top collaborators of Eldad Zacksenhaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eldad Zacksenhaus. Eldad Zacksenhaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 12
4 2
5 20
6 2
7 4
8 4
9 10
10 96
11 20
12 48
13 29
14 14
15 65
16 106
17 19
18 133
19 41
20 93

About Eldad Zacksenhaus

Eldad Zacksenhaus is a scholar working on Oncology, Hematology and Ophthalmology, having authored 105 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (32 papers), Ubiquitin and proteasome pathways (13 papers) and Ocular Oncology and Treatments (11 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (718 citations) and Molecular Biology (2.2k citations). Eldad Zacksenhaus has collaborated with scholars based in Canada, China and United States. Frequent co-authors include Zhe Jiang, Jeff C. Liu, Brenda L. Gallie, Robert A. Phillips, Sean E. Egan, Yaacov Ben‐David, Tao Deng, Rod Bremner, Dong‐Yu Wang and Jamey D. Marth. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026